Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy

IMPORTANCE: In the past decade, the use of neoadjuvant therapy (NAT) has increased for patients with borderline and locally advanced pancreatic ductal adenocarcinoma (PDAC). Data on pancreatic fistula and related overall survival (OS) in this setting are limited. OBJECTIVE: To compare postoperative...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Surg
Glavni autori: Hank, Thomas, Sandini, Marta, Ferrone, Cristina R., Rodrigues, Clifton, Weniger, Maximilian, Qadan, Motaz, Warshaw, Andrew L., Lillemoe, Keith D., Fernández-del Castillo, Carlos
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2019
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6694396/
https://ncbi.nlm.nih.gov/pubmed/31411659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamasurg.2019.2272
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items